Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare research priorities

This article was originally published in The Gray Sheet

Executive Summary

The Medicare Evidence Development and Coverage Advisory Committee will convene April 30 in Baltimore, Md., to discuss priorities for research topics important to the Medicare program. The meeting is a follow-up to MedCAC's Oct. 22 meeting on the issue (1"The Gray Sheet" Nov. 12, 2007, p. 8)

You may also be interested in...

In Need Of Evidence: Medicare Panel Prioritizes Research Efforts

Top research priorities for the elderly should include looking at carotid artery stenting, radiation therapy and prognostic markers for cancer, as well as a number of other areas applicable to devices and diagnostics, says the Medicare Evidence Development and Coverage Advisory Committee

Upgraded Paige Suite Gains CE-IVD and UKCA Marks

Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.

Sanofi Scores In Second-Line Myeloma But Still In Darzalex’s Shadow

The French company believes it has the best-in-class CD38 antibody with new PFS data, but Johnson & Johnson and Genmab’s Darzalex looks set to retain its advantage in multiple myeloma.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts